The non-small cell lung cancer (NSCLC) patients with low TYMS expression also had statistically significantly longer overall survival (OS) and progression-free survival (PFS) compared to those with high TYMS [23], and low TYMS protein expression is a favorable predictive factor for better OS/PFS in NSCLC patients. The gene discussed is TYMS; the disease is non-small cell lung carcinoma.